Α-1,3-fucosyltransferase-vii Stimulates the Growth of Hepatocarcinoma Cells Via the Cyclin-Dependent Kinase Inhibitor P27kip1

Q. Y. Wang,P. Guo,L. L. Duan,Z. H. Shen,H. L. Chen

DOI: https://doi.org/10.1007/s00018-004-4349-8

IF: 8

2005-01-01

Cellular and Molecular Life Sciences

Abstract:After the transfection of α-1,3-fucosyltransferase (FucT)-VII cDNA into H7721 human hepatocarcinoma cells, the protein expression of some cyclins, cyclin-dependent kinases (CDKs) and cyclin-dependent kinase inhibitors (CDIs) p16INK4 and p21waf1/Cip1 were unchanged. However, CDI p27Kip1 protein, both the total amount and the amount that bound to CDK2, but not its mRNA, was significantly reduced. The de-inhibited CDK2 stimulated the phosphorylation of retinoblastoma (Rb) protein and facilitated the G1/S transition and growth rate of the cells. The decrease of p27Kip1 protein, the increase of CDK2 activity and Rb phosphorylation, as well as the cell growth and percentage of S phase cells were correlated to the increased amount of cell surface sialyl Lewis X (SLex) antigen in cells with different α-1,3-FucT-VII expression. The reduction in p27Kip1 and the difference in its expression among different transfected cells were blocked by the SLex antibody KM93 in a dose-dependent manner, indicating that p27Kip1 expression was influenced by α-1,3-FucT-VII and its product SLex. The MEK/MAPK signaling pathway was more important than the PI-3K pathway in the regulation of p27Kip1 expression.